Pearl Therapeutics' Acquisition

Pearl Therapeutics was acquired by AstraZeneca on June 10, 2013.

Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. …

Articles about Pearl Therapeutics' Acquisition: